Rebecca Tay

740 citations
22 papers · 512 indexed · h-index 11
Topics
Lung Cancer Treatments and Mutations (12 papers)Lung Cancer Research Studies (11 papers)Cancer Immunotherapy and Biomarkers (6 papers)

In The Last Decade

Rebecca Tay

21 papers receiving 504 citations

Peers

Rebecca Tay
Comparison fields: 5 of 57
  • Oncology 412
  • Pulmonary and Respiratory Medicine 211
  • Molecular Biology 88
  • Surgery 68
  • Immunology 64
Replace Shinichiro Shimamatsu with:
Shinichiro Shimamatsu Japan
Francesca Sperandi Italy
Xiaole Zhu China
Sara A. Väyrynen Finland
Simon Wabitsch Germany
Keita Uchino Japan
Mariachiara Santorsola Italy
Chia-Chun Kuo Taiwan
Go Ohira Japan
Daizo Kishino Japan
Rebecca Tay relative to Shinichiro Shimamatsu Japan Shinichiro Shimamatsu's profile →
Citations per field
00.5×1.5×1.8×
Shinichiro Shimamatsu · 1×
Citations per year

Countries citing papers authored by Rebecca Tay

Since Specialization
Citations

This map shows the geographic impact of Rebecca Tay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Tay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Tay more than expected).

Fields of papers citing papers by Rebecca Tay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Tay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Tay. The network helps show where Rebecca Tay may publish in the future.

Co-authorship network of co-authors of Rebecca Tay

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Tay. A scholar is included among the top collaborators of Rebecca Tay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Tay. Rebecca Tay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 1
5 56
6 14
7 33
8 5
9 150
10 18
11 8
12 28
13 35
14 3
15 28
16 84
17 9
18 13
19 17
20 5

About Rebecca Tay

Rebecca Tay is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology, having authored 22 papers that have together received 512 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Research Studies (11 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Oncology (412 citations), Pulmonary and Respiratory Medicine (211 citations) and Cancer Research (61 citations). Rebecca Tay has collaborated with scholars based in United Kingdom, Australia and Italy. Frequent co-authors include Raffaele Califano, Arsela Prelaj, Nathalie Chaput, Roberto Ferrara, Benjamin Besse, Sanjeev Gill, Elizabeth F. Blackley, Peter Bergin, Andrew Haydon and Catriona McLean. Their work appears in journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026